Acute respiratory distress syndrome (ARDS) is an overwhelming inflammatory disorder of
the lung due to direct and indirect insults to the lungs. ARDS is characterized by increased …

The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

Background Emerging reports have shown the benefits of steroids in hospitalized COVID-19
patients as life-saving drugs. However, the use of steroids in COVID-19 patients is confusing …

Background Some unanswered questions persist regarding the effectiveness of
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …

Background Patients with severe COVID-19 seem to evolve with a compromised antiviral
response and hyperinflammation. Neutrophils are critical players in COVID-19. IL-17A plays …

Introduction Many immunomodulators have been studied in clinical trials for the treatment of
coronavirus disease 2019 (COVID-19). However, data identifying the most effective and …

The World Health Organization announced that COVID-19, with SARS-CoV-2 as its
pathogen, had become a pandemic on 11 March 2020. Today, the global epidemic situation …

SARS-CoV-2 is the cause of the COVID-19 pandemic which has claimed more than 6.5
million lives worldwide, devastating the economy and overwhelming healthcare systems …

Background Administration of glucocorticoids might reduce mortality in patients with severe
COVID-19 but have adverse cardiometabolic effects. Objectives to investigate the effect of …

Corticosteroids use for COVID-19: an overview of systematic reviews - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …